Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CpG island methylation, response to combination chemotherapy, and patient survival in advanced microsatellite stable colorectal carcinoma

19 Mar 2007

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Colorectal Cancer Screening and Detection
Share to Epigenetics and DNA Methylation
Share to Genetic factors in colorectal cancer

Source

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Identifiers

PMID: 17372756
DOI: 10.1007/s00428-007-0398-3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CpG island methylation, response to combination chemotherapy, and patient survival in advanced microsatellite stable colorectal carcinomaPMID 17372756Read ↗

Prognostic implications of CpG island hypermethylator phenotype in colorectal cancersSemantic proximity Read ↗

CpG island methylator phenotype is an independent predictor of survival benefit from 5-fluorouracil in stage III colorectal cancer.Semantic proximity Read ↗

The CpG Island Methylator Phenotype Status in Synchronous and Solitary Primary Colorectal Cancers: Prognosis and Effective Therapeutic Drug Prediction.Semantic proximity Read ↗

CpG island methylator phenotype is associated with the efficacy of sequential oxaliplatin- and irinotecan-based chemotherapy and EGFR-related gene mutation in Japanese patients with metastatic colorectal cancer.Semantic proximity Read ↗

Chemosensitivity and Survival in Gastric Cancer Patients with Microsatellite InstabilitySemantic proximity Read ↗

DNA copy number profiles of primary tumors as predictors of response to chemotherapy in advanced colorectal cancerSemantic proximity Read ↗

Correlation between the promoter methylation status of ATP-binding cassette sub-family G member 2 and drug sensitivity in colorectal cancer cell linesSemantic proximity Read ↗

Tumor mutation burden is correlated with response and prognosis in microsatellite-stable (MSS) gastric cancer patients undergoing neoadjuvant chemotherapySemantic proximity Read ↗

Activity of temozolomide in patients with advanced chemorefractory colorectal cancer and MGMT promoter methylationSemantic proximity Read ↗

Long interspersed nuclear element-1 hypomethylation is a potential biomarker for the prediction of response to oral fluoropyrimidines in microsatellite stable and CpG island methylator phenotype-negative colorectal cancer.Semantic proximity Read ↗

Association of somatic DNA methylation variability with progression-free survival and toxicity in ovarian cancer patientsSemantic proximity Read ↗

Prognostic role of APC and RASSF1A promoter methylation status in cell free circulating DNA of operable gastric cancer patientsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.